Kinney Drugs Foundation Inc.

Kinney Drugs Foundation Inc. is the philanthropic arm of KPH Healthcare Services (Kinney Drugs' parent), based in Gouverneur, NY, and has given more than $11-12 million since its 2002 founding. Its giving profile — 360 recorded grants totaling $2.14M in the sampled data at an average of $5,950 — shows a foundation built for high-volume, relationship-based community sponsorship rather than competitive, program-based grantmaking. The board (President Dave McClure, VP Richard McNulty, Secretary/Treasurer role held historically by Stephen McCoy and per the Foundation's 2025 site by Ben Greene, plus seven pharmacy-credentialed directors) is drawn almost entirely from Kinney Drugs/KPH leadership, meaning proposals succeed or fail on alignment with the parent company's regional footprint and health-care identity, not on grantwriting polish alone. First-time applicants should know three things: (1) 94% of grantees identified in the data are in NY (283 of 360) or VT (61 of 360) — this is a hyper-local funder tied to towns with an operating Kinney Drugs store; (2) the modal gift is small ($1,000 median per the Foundation's own typical_grant_size data, $100-$181,262 range) and tied to a specific event, walk, gala, or campaign rather than general operating support; (3) exceptions exist for marquee regional hospital partners (Oswego Health's $250,000 four-year capital commitment) where the Foundation will scale up dramatically for facility/patient-care projects visibly branded with its name. The relationship progression is lightweight: complete the online request-funding form (no LOI-to-full-proposal staging is documented), tie the ask to a named event or campaign with a date, and expect a board-meeting-cycle decision rather than a multi-month review. Health care and health-adjacent human services (EMS, fire/rescue squads, food pantries) are favored; organizations outside health, aging, or emergency services are a weaker fit. There is no evidence in the data of a competitive RFP cycle, cohort-based grant round, or formal site-visit stage — the process reads as a rolling, relationship-driven sponsorship pipeline that mirrors how a regional retail pharmacy chain supports the towns where it operates stores, rather than a professionally staffed program-officer model. Applicants should therefore treat their local Kinney Drugs store manager or regional operations contact, where one exists, as a potential internal advocate, since board composition is drawn almost entirely from company leadership rather than outside community representatives.

The Foundation's own reported typical_grant_size (based on 114 sampled grants) shows a median of just $1,000, an average of $6,358, and a full range of $100 to $181,262 — confirming this is fundamentally a small-check, high-frequency sponsor. Looking at the top 50 cumulative-grantee dataset (which aggregates each organization's 2-3 grants over the sampled years), the picture shifts: Children's Miracle Network tops the list at $603,244 across 3 grants (its largest and longest-running partner, dating to 1992), followed by Oswego Health Foundation ($165,000/3 grants), Crouse Health Foundation ($161,000/3 grants), Albany College of Pharmacy ($90,000/3 grants — reflecting KPH's pharmacy-industry ties), and Upstate Foundation ($65,000/3 grants). Below the top ~10 recipients, cumulative totals drop quickly into the $5,000-$60,000 band, and the tail is dense with $5,000-$15,000 event sponsorships (American Red Cross, Alzheimer's Association, MS Society, cancer walks, hospital golf classics). Geographically, of 360 tracked grants, 283 (79%) went to New York and 61 (17%) to Vermont, with small single-digit counts trickling into MO, PA, UT, VA, and WI (likely national-charity headquarters gifts, e.g., American Red Cross, St. Jude). By program area, health care/hospital-affiliated giving dominates (hospital foundations, CMN, cancer/heart/diabetes associations, EMS), consistent with the Foundation's stated mission. On the finance side, total assets have grown steadily from $3.09M (FY2012) to $6.48M (FY2024); total giving has been volatile year to year — $729K (2012), a dip to $652K (2022), then a jump to $1.16M (2023) — driven by contributions from Kinney Drugs/KPH corporate rather than investment returns, since net investment income is a modest secondary revenue source ($70K-$658K annually, no clear trend). Officer compensation for the Executive Director role has ranged from roughly $52,500 (2013) to $87,444 (2022), landing at $71,583 in FY2023 — modest relative to total giving, consistent with a lean, corporately-supported administrative structure rather than a large independent staff. Grants paid (cash disbursed in-year) has swung from a low of $474,334 (2022) to a high of $1,025,592 (2023), suggesting giving capacity tracks corporate contributions from Kinney Drugs/KPH more closely than it tracks the Foundation's own asset base or investment performance.

The peer set here is asset-matched (all ~$6.48M in total assets, per the NTEE "Philanthropy & Grantmaking" cohort) but is otherwise a poor thematic match — none of the five peers share Kinney's health-care focus, corporate-giving structure, or NY/VT geography, and public data on their giving levels and application processes is largely undisclosed. Kinney stands out among this asset-tier group for being unusually operationally transparent (published mission, public request-funding form, documented grantee list) and for channeling giving through a corporate parent (KPH Healthcare) rather than a family or individual endowment, which explains its much higher grant volume (360 grants tracked) relative to typical asset-matched peers. A more instructive real-world comparison is with other retail/corporate-affiliated health foundations of similar scale — organizations like regional hospital-system auxiliary foundations or drugstore-chain community funds — which typically share Kinney's pattern of many small event sponsorships punctuated by occasional large capital gifts to flagship partner institutions; grant seekers should benchmark their ask size against that hybrid model rather than against a traditional program-officer-staffed private foundation of comparable asset size.

The clearest recent-activity signal is the Foundation's 34th annual Children's Miracle Network campaign, which ran across 16 Kinney Drugs store locations in Jefferson, Lewis, and St. Lawrence counties, NY, over a seven-week period in spring 2025 and raised more than $54,000 — part of a partnership dating to 1992 that has generated over $4 million cumulatively for six regional children's hospitals (reported via Samaritan Medical Center's Angie VanWormer, Director of Children's Miracle Network). The Foundation also ran its signature Charity Golf Tournament on June 17, 2025 at Thousand Islands Golf Club on Wellesley Island, NY — its flagship annual fundraising event and a recurring engagement opportunity for grantee organizations and community partners. No major leadership transition was found in 2025-2026 web sources, though the Foundation's own About page (crawled 2025) lists Ben Greene as Secretary/Treasurer, a change from the Stephen McCoy attribution in the IRS 990 filing data — worth confirming directly before addressing correspondence, since 990 data can lag current officers by a filing cycle. No 2025-2026 press specifically named new grant recipients or dollar figures beyond the CMN campaign; the most recent large capital commitment on record remains the $250,000, four-year Oswego Health Foundation grant (announced April 2021) for hospital floor construction and the Lakeview Center for Mental Health & Wellness — still the best available benchmark for how the Foundation structures its largest gifts (multi-year, capital-project-tied, publicly co-branded).

Apply through the online request-funding form at kinneydrugsfoundation.com/en/donate/request-funding/ — there is no separate LOI stage documented; the form itself functions as the full application, asking for legal organization name, Tax ID/EIN, 501(c)(3) status, geographic service area, mission/program description, and evidence that a reasonable share of funds directly reaches client services. Submit at least one month before the board meeting nearest your event date — the Foundation explicitly gates review cycles to board meetings tied to a stated event, so applicants without a fixed event date (e.g., general operating requests) may struggle to fit the process; frame the ask around a specific, dated activity (a walk, gala, golf tournament, capital-campaign milestone, or awareness event) rather than an open-ended program budget, mirroring the overwhelming majority of the Foundation's recorded grant purposes. A frequent technical pitfall flagged on the Foundation's own site: do not paste text copied from a Word document or PDF into the web form — invisible formatting characters can silently break submission; retype or paste as plain text. Given that median gift size is $1,000 and average is $6,358, first-time applicants should calibrate expectations to a sponsorship-level ask ($1,000-$15,000) rather than a five- or six-figure program grant; only well-established regional hospital systems and CMN-affiliated partners have received awards in the $50,000-$600,000+ range, typically after years of prior smaller sponsorships. Use direct alignment language with the Foundation's stated mission to help people live healthier lives and its focus on hospitals, EMS/fire/rescue, disease-specific associations (heart, cancer, diabetes, cystic fibrosis, MS), and children's health — proposals outside health care or health-adjacent emergency/community services are a weak fit regardless of quality. Because board seats are held by Kinney Drugs/KPH executives and pharmacy professionals, organizations with a presence in a town that has an active Kinney Drugs retail location have a structural advantage; consider referencing local store relationships or existing register-donation/community partnerships in the narrative. Build the relationship over multiple annual cycles — most top grantees show 2-3 recorded gifts across the sampled years, suggesting the Foundation renews rather than one-off funds successful partners.